Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Melphalan 50 MG Injection [Evomela]

Known as: Evomela 50 MG (equivalent to 56 MG melphalan HCl) Injection, Evomela 50 MG Injection, MELPHALAN HYDROCHLORIDE 50 mg in 10 mL INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [EVOMELA] 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Background Carmustine, etoposide, cytarabine and melphalan (BEAM) is the most common conditioning regimen for autologous… Expand
2019
2019
Background High-dose melphalan is the most common conditioning regimen for patients with multiple myeloma (MM) undergoing… Expand
Review
2018
Review
2018
Background: High-dose chemotherapy followed by autologous stem cell transplantation (SCT) is the current standard of care for… Expand
2018
2018
Abstract Purpose: The objective of this study was to compare the stability of recently approved Captisol-stabilized propylene… Expand
2017
2017
Background: Melphalan exposure as measured by area under the curve (AUC) has a 5-fold variability between patients, with higher… Expand
Review
2017
Review
2017
Background: For multiple myeloma (MM) and AL amyloidosis (AL) patients undergoing autologous hematopoietic stem cell transplant… Expand
Review
2016
Review
2016
High-dose melphalan has been the drug of choice for preparative regimens for autologous stem cell transplantation in multiple… Expand